Last Update 26 Apr 26

FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook

Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.

Analyst Commentary

Bullish Takeaways

Bullish analysts lifting the price target highlight room for the shares to better reflect their preferred P/E assumptions, suggesting they see the current valuation as not fully capturing the company’s earnings profile.
The recent upgrade in stance points to improved confidence in execution, with expectations that management can deliver against its plan closely enough to justify a higher valuation framework.
Positive commentary implies that, at current levels, the risk and reward trade off is viewed as acceptable by bullish analysts, especially if margins and cash generation track internal models.
The move to raise the target after a prior reduction signals that at least some of the earlier concerns built into discount rates or P/E inputs may now be viewed as less pressing.

Bearish Takeaways

Bearish analysts trimming their price targets indicate that, in their view, the shares already price in a fuller set of expectations, leaving less room for upside if execution or end markets prove uneven.
The cut to the target by a larger amount earlier in the period suggests concern that previous valuation inputs, including the assumed P/E and discount rate, were too optimistic for current conditions.
More cautious commentary tends to reflect worries about the consistency of growth and profitability, with analysts building in a wider range of possible outcomes to their models.
The mix of upward and downward target moves underscores that there is still debate around how reliable earnings visibility is, which can cap how aggressive some analysts are willing to be on valuation.

What's in the News

H.B. Fuller raised full year fiscal 2026 guidance, now expecting net revenue to be up mid single digits. This provides a clearer view of management’s current outlook for the business (Corporate guidance, raised).
The company issued guidance for the second quarter of 2026, with net revenue expected to be up low single digits. This helps frame near term expectations around sales trends (Corporate guidance, new/confirmed).
H.B. Fuller reported that from November 30, 2025 to February 28, 2026, it repurchased 0 shares for $0, while completing a total of 1,384,937 shares repurchased for $88.74 million, or 2.54% of shares, under the buyback announced on April 7, 2022 (Buyback tranche update).

Valuation Changes

Fair Value: $70.43 is unchanged, with the updated estimate matching the prior figure.
Discount Rate: 8.42% to 8.46%, risen slightly, implying a modestly higher required return in the model.
Revenue Growth: 4.45% to 4.45%, effectively unchanged, keeping top line assumptions steady.
Net Profit Margin: 6.19% to 6.19%, effectively unchanged, indicating similar expectations for profitability.
Future P/E: 20.26x to 20.65x, risen slightly, reflecting a marginally higher valuation multiple applied to future earnings.

0 views

Key Takeaways

Strategic pricing, portfolio optimization, and cost structure improvements aim to enhance profitability and achieve margin targets as raw material pressures ease.
Acquisitions and share repurchases indicate potential earnings growth and enhanced shareholder value through strategic expansion and stock buybacks.
Ongoing challenges in the solar segment, market demand, and geopolitical conditions threaten H.B. Fuller’s revenue growth and profitability.

Catalysts

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products.What are the underlying business or industry changes driving this perspective?

H.B. Fuller is focused on maintaining pricing discipline and securing additional pricing gains, particularly in the HHC segment, which is expected to improve EBITDA margins as raw material cost pressures subside. This pricing strategy is likely to positively impact revenue and margins.
The company's strategic initiatives, such as optimizing the portfolio mix and streamlining the manufacturing cost structure, aim to drive the business toward a greater than 20% EBITDA margin target, potentially enhancing profitability and earnings.
H.B. Fuller's efforts in leveraging its unique operating model to reduce exposure to currency fluctuations and tariffs are designed to maintain a competitive edge and support margin expansion, which can improve net margins and financial stability.
The acquisition of ND Industries and restructuring benefits are contributing to EBITDA growth, particularly in the Engineering Adhesives segment, indicating potential future revenue and earnings growth from these strategic actions.
Share repurchases are prioritized due to recent market volatility, with an ongoing focus on opportunistic buybacks, potentially driving EPS growth by reducing share count and enhancing shareholder value.

H.B. Fuller Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming H.B. Fuller's revenue will grow by 4.5% annually over the next 3 years.
Analysts assume that profit margins will increase from 4.6% today to 6.2% in 3 years time.
Analysts expect earnings to reach $243.6 million (and earnings per share of $3.82) by about April 2029, up from $159.8 million today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 20.7x on those 2029 earnings, down from 21.4x today. This future PE is lower than the current PE for the US Chemicals industry at 29.6x.
Analysts expect the number of shares outstanding to grow by 0.97% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.46%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

The ongoing challenges in the solar segment, resulting in a decline in organic revenue by 2%, could continue to weigh on H.B. Fuller’s revenues and overall profitability, impacting earnings.
Weak overall market demand and unpredictable geopolitical conditions are causing concerns for market dynamics, particularly in HHC and other segments, potentially leading to lower revenue growth.
Higher raw material costs have been outstripping positive pricing and volume leverage, contributing to a year-on-year decline in EBITDA, thus affecting net margins and profitability.
The company has a high net debt to EBITDA ratio of 3.5x, above their long-term target, which could limit financial flexibility and impact cash flows needed for growth initiatives and debt reduction.
Currency fluctuations and foreign exchange negatively impacted adjusted EBITDA by approximately $5 million year-on-year, posing a risk to revenue and profit margins given the global nature of their operations.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $70.43 for H.B. Fuller based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $84.0, and the most bearish reporting a price target of just $58.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $3.9 billion, earnings will come to $243.6 million, and it would be trading on a PE ratio of 20.7x, assuming you use a discount rate of 8.5%.
Given the current share price of $62.83, the analyst price target of $70.43 is 10.8% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on H.B. Fuller?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

ND Industries Integration And HHC Pricing Will Secure Stability